Cancer and fertility preservation: Barcelona consensus meeting

Gynecological Endocrinology

Volumn 29, Issue 4, 2013, Pages 285-291

  Martínez, Francisca ^a   Devesa, Marta ^a   Coroleu, Buenaventura ^a   Tur, Rosa ^a   González, Clara ^a   Boada, Montserrat ^a   Solé, Miquel ^a   Veiga, Anna ^a,b   Barri, Pedro N ^a  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b CENTER OF REGENERATIVE MEDICINE IN BARCELONA   (Spain)

Author keywords

Cancer; Consensus; Fertility preservation; Oocyte vitrification; Ovarian tissue cryopreservation

Indexed keywords

ESTRADIOL; FOLLITROPIN;

ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CONSENSUS; COPING BEHAVIOR; CRYOPRESERVATION; DNA DAMAGE; EARLY DIAGNOSIS; EMOTION; FEMALE FERTILITY; FOLLICULAR PHASE; FREEZING; GERMLINE STEM CELL; HUMAN; IN VITRO OOCYTE MATURATION; META ANALYSIS (TOPIC); NEOPLASM; OOCYTE RETRIEVAL; OVARIECTOMY; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVARY HYPERSTIMULATION; PATIENT CARE; PATIENT COUNSELING; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RADIATION EXPOSURE; REPRODUCTION; REPRODUCTIVE PROCEDURE; SURVIVAL RATE; TISSUE TRANSPLANTATION; VITRIFICATION; WHOLE BODY RADIATION; FEMALE; FEMALE INFERTILITY; METHODOLOGY; REVIEW;

CONSENSUS; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; NEOPLASMS;

EID: 84883180122     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.743019     Document Type: Article

References (71)

1. Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012;118:1710-7.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6:209-18.
4. Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009;45:992-1005.
5. Scotting PJ, Walker DA, Perilongo G. Childhood solid tumours: a developmental disorder. Nat Rev Cancer 2005;5:481-8.
6. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD. Available from: http://seer.cancer.gov/csr/1975-2002/, based on November 2004 SEER data submission, posted to the SEER website, 2005; [Last accessed 27 Dec 2012].
7. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 2009;27:2308-18.
8. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 2003;290:1583-92.
9. Mart́in I, Valls C, Pavía C, et al. Gonadal function and puberty assessment in a cohort of Spanish pediatric survivors of childhood cancer. Endocrinologist 2009;19:133-41.
10. Cancer Research UK. Cancer Incidence by Age 2009. Available at: http://info.cancerresearchuk.org/cancerstats/[Last accessed 27 Dec 2012].
11. Schmidt KT, Larsen EC, Andersen CY, Andersen AN. Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease. BJOG 2010;117:163-74.
12. Hudson MM, Mulrooney DA, Bowers DC, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol 2009;27:2405-14.
13. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-31.
14. Broekmans FJ, Knauff EA, te Velde ER, et al. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 2007;18:58-65.
15. Wallace WH, Kelsey TW. Human ovarian reserve from conception to menopause. PLoS ONE 2010;5:e8772.
16. Rosendahl M, Andersen CY, la Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril 2010;94:156-66.
17. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-43.
18. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727-39.
19. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2006;91:1723-8.
20. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17:2365-70.
21. Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
22. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-30.
23. Lie Fong S, Lugtenburg PJ, Schipper I, et al. Anti-Müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008;23:674-8.
24. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010;94:638-44.
25. Anderson RA, Cameron DA. Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 2011;96:1336-43.
26. Greve T, Schmidt KT, Kristensen SG, et al. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue. Fertil Steril 2012;97:1394.1398.e.1.
27. Meirow D, Baum M, Yaron R, et al. Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience. Leuk Lymphoma 2007;48:1569-76.
28. Wallace WH, Thomson AB. Preservation of fertility in children treated for cancer. Arch Dis Child 2003;88:493-6.
29. Norwitz ER, Stern HM, Grier H, Lee-Parritz A. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol 2001;98:929-31.
30. Critchley HO, Wallace WH. Impact of cancer on uterine function. J Natl Cancer Inst Monogr 2005;34:64-8, doi: 10.1093/jncimono-graphs/lgi022.
31. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007;12:1044-54.
32. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreserva-tion. J Clin Oncol 2005;23:4347-53.
33. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91:3885-90.
34. Oktay K, Türkçüoglu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010;20:783-8.
35. Quintero RB, Helmer A, Huang JQ, Westphal LM. Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril 2010;93:865-8.
36. Garcia-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril 2012;97:527-8.
37. Friedler S, Koc O, Gidoni Y, et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012; 97:125-33.
38. Bedoschi GM, de Albuquerque FO, Ferriani RA, Navarro PA. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet 2010;27:491-4.
39. Oktay K, Demirtas E, Son WY, et al. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008;89:228.e19-22.
40. Demirtas E, Elizur SE, Holzer H, et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 2008;17:520-3.
41. Maman E, Meirow D, Brengauz M, et al. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril 2011;95:64-7.
42. Chian RC, Huang JY, Gilbert L, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 2009;91:2391-8.
43. Cao YX, Chian RC. Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med 2009;27:456-64.
44. Parmegiani L, Bertocci F, Garello C, et al. Efficiency of human oocyte slow freezing: results from five assisted reproduction centres. Reprod Biomed Online 2009;18:352-9.
45. Kuwayama M, Vajta G, Kato O, Leibo P. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005;11:300-8.
46. Smith GD, Serafini PC, Fioravanti J, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril 2010;94:2088-95.
47. Tulandi T, Huang JY, Tan SL. Preservation of female fertility: an essential progress. Obstet Gynecol 2008;112:1160-72.
48. Nagy ZP, Chang CC, Shapiro DB, et al. The efficacy and safety of human oocyte vitrification. Semin Reprod Med 2009;27:450-5.
49. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011;96:277-85.
50. Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010;25:66-73.
51. Ubaldi F, Anniballo R, Romano S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod 2010;25:1199-205.
52. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009;18:769-76.
53. Son WY, Tan SL. Comparison between slow freezing and vitrification for human embryos. Expert Rev Med Devices 2009;6:1-7.
54. Parmegiani L, Accorsi A, Cognigni GE, et al. Sterilization of liquid nitrogen with ultraviolet irradiation for safe vitrification of human oocytes or embryos. Fertil Steril 2010;94:1525-28.
55. Andersen CY, Rosendahl M, Byskov AG, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008;23:2266-72.
56. Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryo-preservation. Fertil Steril 2012;97:387-90.
57. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online 2005;10:729-34.
58. Keros V, Xella S, Hultenby K, et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod 2009;24:1670-83.
59. Silber SJ. Ovary cryopreservation and transplantation for fertility preservation. Mol Hum Reprod 2012;18:59-67.
60. Rosendahl M, Schmidt KT, Ernst E, et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 2011;22:162-71.
61. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011;43:437-50.
62. Revel A, Laufer N, Ben Meir A, et al. Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod 2011;26:1097-103.
63. Grynberg M, Poulain M, Sebag-Peyrelevade S, et al. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril 2012;97:1260-8.
64. Martinez-Madrid B, Donnez J. Cryopreservation of intact human ovary with its vascular pedicle: or cryopreservation of hemiovaries? Hum Reprod 2007;22:1795.
65. Patrizio P, Gavish Z, Martel M, et al. Whole human ovaries cryopreservation using a novel multi-gradient freezing device. Fertil Steril 2007;88:S355.
66. Bedaiwy MA, Hussein MR, Biscotti C, Falcone T. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod 2006;21:3258-69.
67. Harris SE, Adriaens I, Leese HJ, et al. Carbohydrate metabolism by murine ovarian follicles and oocytes grown in vitro. Reproduction 2007;134:415-424.
68. Newton H, Picton HM, Gosden RG. In vitro growth of oocyte-granulosa cell complexes isolated from cryopreserved ovine tissue. J Reprod Fertil 1999;115:141-150.
69. Picton HM, Harris SE, Muruvi W, Chambers EL. The in vitro growth and maturation of follicles. Reproduction 2008;136:703-15.
70. Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20:1880-9.
71. de Ziegler D, Streuli I, Vasilopoulos I, et al. Cancer and fecundity issues mandate a multidisciplinary approach. Fertil Steril 2010;93: 691-6.